Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-27

Clinical Trial Update: Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is described comparing gastric bypass surgery to Exenatide for Type 2 diabetes, with the current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Wu Qinan | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN